REnewable SOLVEnts with high performance in application and improved toxicity profile
ReSolve sets out to replace two hazardous solvents – toluene and NMP (N-methyl-2-pyrrolidone) – with safer alternatives derived from non-food carbohydrates. These new solvents will omit parts of the molecular structure that cause toxicity – namely aromatic rings (toluene) and amide groups (NMP). The new, safer solvents will have a wide range of applications; project ReSolve with bring them to Technology Readiness Level (TRL) 5. It will also demonstrate their sustainability, low health impact and high application performance of the bio-based solvents.
These bio-based solvents will allow Europe’s solvent industry to avoid the negative economic impact of the regulatory restrictions on the use of aromatic and nitrogen-containing solvents. It will also make a difference for many thousands of downstream users, while reducing the health impact on millions of European citizens that are routinely exposed to solvents as part of their job.
In addition, ReSolve intends to create a pipeline of new solvent candidates. This means that as well as having candidates at TRL 5, there will also be other candidates for specific applications moving towards to TRL 3-4, offering further substitution options for hazardous solvents in the near future.
ACTIVITIES of Bio Base Europe Pilot Plant
Bio Base Europe Pilot Plant will use its expertise in process development and green chemistry to implement, optimize and scale-up the production of a novel solvent.
DOWNLOADS and LINKS:
- Stichting WAGENINGEN RESEARCH, The Netherlands
- NOVA-INSTITUT für politische und ökologische innovation GMBH, Germany
- NITTO Belgium, Belgium
- AVANTIUM CHEMICALS BV, The Netherlands
- CIRCA sustainable chemicals Limited, UK
- BioDetection Systems B.V., The Netherlands
- PROCESS DESIGN CENTER BV, The Netherlands
- NORSKE SKOGINDUSTRIER ASA, Norway
- Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO, The Netherlands
- Bio Base Europe Pilot Plant VZW, Belgium
SUPPORTED by: This project has received funding from the Bio Based Industries Joint Undertaking under the European Union´s Horizon2020 research and innovation programme under agreement No 745450